Skip to content
Source: Library

AHA: Identifying the Effects of GLP-1 Medications on CKM Disease - due Jan. 19, 2026

by American Heart Association

Deadline
Contact funder
Award Amount
Varies
Eligibility
Business, Nonprofit

About this opportunity

Full details for this opportunity are available on the official funder website. View the official posting for complete information about eligibility, requirements, and how to apply.

AHA: Identifying the Effects of GLP-1 Medications on CKM Disease - due Jan. 19, 2026 | Funding Landscape | Funding Landscape